Literature DB >> 11371627

FGF23, hypophosphatemia, and rickets: has phosphatonin been found?

G J Strewler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11371627      PMCID： PMC33399          DOI： 10.1073/pnas.111154898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

Review 1.  The physiology of parathyroid hormone-related protein.

Authors:  G J Strewler
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Disorders of phosphate metabolism.

Authors:  L A DiMeglio; K E White; M J Econs
Journal:  Endocrinol Metab Clin North Am       Date:  2000-09       Impact factor: 4.741

Review 3.  Proximal tubular phosphate reabsorption: molecular mechanisms.

Authors:  H Murer; N Hernando; I Forster; J Biber
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

4.  The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

Authors:  K E White; K B Jonsson; G Carn; G Hampson; T D Spector; M Mannstadt; B Lorenz-Depiereux; A Miyauchi; I M Yang; O Ljunggren; T Meitinger; T M Strom; H Jüppner; M J Econs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  Effect of P(i) restriction on renal Na(+)-P(i) cotransporter mRNA and immunoreactive protein in X-linked Hyp mice.

Authors:  H S Tenenhouse; J Martel; J Biber; H Murer
Journal:  Am J Physiol       Date:  1995-06

6.  Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.

Authors:  S Fukumoto; Y Takeuchi; A Nagano; T Fujita
Journal:  Bone       Date:  1999-09       Impact factor: 4.398

7.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.

Authors:  L Pellegrini; D F Burke; F von Delft; B Mulloy; T L Blundell
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

8.  MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

Authors:  P S Rowe; P A de Zoysa; R Dong; H R Wang; K E White; M J Econs; C L Oudet
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

9.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

10.  Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

Authors:  T Yamashita; M Yoshioka; N Itoh
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575
View more
  12 in total

1.  Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.

Authors:  Vikash Kumar Dubey; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

2.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

3.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

Review 4.  Inorganic phosphate homeostasis and the role of dietary phosphorus.

Authors:  Eiji Takeda; Hironori Yamamoto; Kunitaka Nashiki; Tadatoshi Sato; Hidekazu Arai; Yutaka Taketani
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

5.  Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.

Authors:  Catherine A Brownstein; Junhui Zhang; Althea Stillman; Bruce Ellis; Nancy Troiano; Douglas J Adams; Caren M Gundberg; Richard P Lifton; Thomas O Carpenter
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

Review 6.  Molecular pathology of the fibroblast growth factor family.

Authors:  Pavel Krejci; Jirina Prochazkova; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 7.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

Review 8.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

9.  FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

Authors:  Mara Riminucci; Michael T Collins; Neal S Fedarko; Natasha Cherman; Alessandro Corsi; Kenneth E White; Steven Waguespack; Anurag Gupta; Tamara Hannon; Michael J Econs; Paolo Bianco; Pamela Gehron Robey
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.

Authors:  Marion Morena; Isabelle Jaussent; Aurore Halkovich; Anne-Marie Dupuy; Anne-Sophie Bargnoux; Leila Chenine; Hélène Leray-Moragues; Kada Klouche; Hélène Vernhet; Bernard Canaud; Jean-Paul Cristol
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.